1. After six months, valgus brace users reported a statistically significant and clinically meaningful reduction in knee pain after walking...
1. Efruxifermin 50 mg once-weekly significantly improved fibrosis at 96 weeks versus placebo. 2. MASH resolution without worsened fibrosis was...
1. Compared to standard care, measurement-based care resulted in faster time to response and time to remission among adults with...
1. 30- and 60-minute C-peptide levels during an OGTT at 16–18 weeks gestation were significantly elevated in women who later...
1. In patients with heart failure with preserved ejection fraction (HFpEF), Beta-blocker use was not associated with concurrent baseline health...
1. In adult patients with Crohn’s disease (CD) treated with risankizumab, only 13% of patients experienced treatment failure while 23%...
1. In this large global cohort study, individuals aged 50 without five major cardiovascular risk factors (hypertension, hyperlipidemia, abnormal body...
1. In a group of Chinese patients with normal low-density lipoprotein cholesterol (LDL-c), serum albumin to creatinine (sACR) showed an...
1. In this randomized controlled trial, the combination cagrilintide-semaglutide (CagriSema) resulted in significantly greater body weight reduction compared to either...
1. In this single-group trial, among infants predicted to develop type 1 spinal muscular atrophy (SMA) who were treated presymptomatically...
